Concepedia

Alexander Roediger

AR

6

Publications

286

Citations

6

H-Index

2009

Active since

Affiliations

MSD (Switzerland)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

European CanCer Organisation

Alexander Roediger is an author at MSD (Switzerland) specializing in cancer research, medicine, and oncology.

ORCID

Top concepts

Publications per year

2009–2023

6

Publications

6

What pricing and reimbursement policies to use for off-patent biologicals in Europe? – results from the second EBE biological medicines policy survey

Jean-Baptiste Reiland, Barbara Freischem, Alexander Roediger · Generics and Biosimilars Initiative Journal · 2017 · 144 citations · Full text

Towards sustainable cancer care: Reducing inefficiencies, improving outcomes—A policy report from the All.Can initiative

Suzanne Wait, Daniel Han, Vivek Muthu et al. · Journal of Cancer Policy · 2017 · 46 citations · Full text

, , +18

The call for a strategic framework to improve cancer literacy in Europe

Kristine Sørensen, Lydia Makaroff, Laurie Myers et al. · Archives of Public Health · 2020 · 37 citations · Full text

Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption

Charlotte Poon, Tim Wilsdon, Alexander Roediger et al. · Frontiers in Public Health · 2023 · 33 citations · Full text

Cost-effectiveness of Raltegravir in Antiretroviral Treatment-Experienced HIV-1–Infected Patients in Switzerland

E.E. Elbasha, Thomas D. Szucs, Mohammad A. Chaudhary et al. · HIV Clinical Trials · 2009 · 14 citations

Rows per page

1–5 of 6